ReShape Lifesciences, Inc. - Common Stock (NQ:RSLS)

3.920 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ReShape Lifesciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Here are the top movers in Wednesday's session. ↗

February 19, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Wednesday's session: gap up and gap down stocks ↗

February 19, 2025

Let's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

February 19, 2025

As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

February 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 18, 2025

Via Benzinga

Why GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket ↗

February 18, 2025

Via Benzinga

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering

February 15, 2025

From ReShape Lifesciences Inc

Via GlobeNewswire

ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology

February 03, 2025

Vagal Neuromodulation Provides Path to Treat Type 2 Diabetes and Hypoglycemia

From ReShape Lifesciences Inc

Via GlobeNewswire

ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

January 13, 2025

Transactions Continue to Progress and Remain on Track

From ReShape Lifesciences Inc

Via GlobeNewswire

ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update

November 14, 2024

From ReShape Lifesciences Inc

Via GlobeNewswire

ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

November 12, 2024

Conference Call to be Held at 4:30 pm ET on Thursday, November 14, 2024

From ReShape Lifesciences Inc

Via GlobeNewswire

ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX

November 12, 2024

FLEX Technology Designed to Improve the Patient Experience

From ReShape Lifesciences Inc

Via GlobeNewswire

Earnings Scheduled For November 14, 2024 ↗

November 14, 2024

Via Benzinga

ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes

November 11, 2024

Approximately $241,000 Grant Will Be Utilized to Conduct Minimally Invasive Laparoscopic Surgical Electrode Implantation Techniques and Long Duration Safety and Blood Glucose Modulation Experiments for...

From ReShape Lifesciences Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 04, 2024

Via Benzinga

Dow Rises Over 50 Points; AutoZone Posts Downbeat Earnings ↗

September 24, 2024

Via Benzinga

Topics Stocks

ReShape Lifesciences Announces 1-for-58 Reverse Stock Split

September 19, 2024

Effective as of Commencement of Trading on September 23, 2024

From ReShape Lifesciences Inc

Via GlobeNewswire

RSLS Stock Earnings: Reshape Lifesciences Misses Revenue for Q2 2024 ↗

August 14, 2024

RSLS stock results show that Reshape Lifesciences missed on revenue for the second quarter of 2024.

Via InvestorPlace

ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update

August 14, 2024

From ReShape Lifesciences Inc

Via GlobeNewswire

ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update

August 13, 2024

Conference Call to be Held at 4:30 pm ET on Thursday, August 15, 2024

From ReShape Lifesciences Inc

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of Shareholders

July 19, 2024

From Halper Sadeh LLC

Via GlobeNewswire

RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLS

July 16, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

RSLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ReShape Lifesciences Inc. Is Fair to Shareholders

July 15, 2024

From Halper Sadeh LLC

Via Business Wire

Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 09, 2024

Via Benzinga

ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

July 09, 2024

From ReShape Lifesciences Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 30, 2024

Via Benzinga

S&P 500 Down 0.5%; Abercrombie & Fitch Earnings Top Views ↗

May 29, 2024

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.